Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation
(ندگان)پدیدآور
Assani, GaniouYessoufou, AkadiriXiong, YudiSegbo, JulienYu, XiaoyuanZhou, FuxiangZhou, Yunfengنوع مدرک
TextResearch Articles
زبان مدرک
Englishچکیده
Background: TMPRSS4 is a novel Type II transmembrane serine protease found at the surface of the cells andis involved in the development and cancer progression. However, TMPRSS4 functions in breast cancer remain poorunderstand. The present study investigated the function of TMPRSS4 in the breast cancer cells and the potentialmechanistic action underling. Materials and Methods: The lentiviral vectors causing TMPRSS4 down-regulation andover-expression were established and transfected in MDA-MB-468 and MCF-7 cells, respectively. By using the CCK-8 assay, cell proliferation was analyzed. Moreover, western blot was used to detect the expression of certain proteinsrelated to cell apoptosis (Bax and Bcl2) signaling pathway and telomere maintenance (POT1, TPP1, and UBE2D3).Cell cycle and cell apoptosis were also analyzed by using the Flow cytometry analysis. TMPRSS4 expression wasdetected at the mRNA level and protein level by performing qPCR and western blot technique, respectively. Results:TMPRSS4 expression is inhibited in stable transfected MDA-MB-468-shTMPRSS4 cells compared to the controlMDA-MB-468-NC and its expression is up-regulated in stable transfected MCF-7-TMPTSS4 compared to its controlMCF-7-NC. Moreover, TMPRSS4 silencing in breast cancer reduces cells proliferation by promoting cell cycle arrestin G2/M phase, cell apoptosis, and telomere maintenance impairment while the TMPRSS4 overexpression increasescells proliferation through cell apoptosis reduction and telomere maintenance reinforcement associated with insignificantchange in cell cycle progression. Conclusion: TMPRSS4 plays important roles in cancer progression and may beconsidered as a good therapeutic target for cancer gene therapy especially breast cancer.
کلید واژگان
TMPRSS4breast cancer
Cell cycle
cell apoptosis
Telomere
Cancer biology
شماره نشریه
6تاریخ نشر
2019-06-011398-03-11
ناشر
West Asia Organization for Cancer Prevention (WAOCP)سازمان پدید آورنده
Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China.University of Abomey Calavi, BP 526, Cotonou, Benin.
Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China.
University of Abomey Calavi, BP 526, Cotonou, Benin.
Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China.
Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China.
Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China.
شاپا
1513-73682476-762X




